自体荧光技术在糖尿病患者并发足溃疡风险评价中的应用
被引量:1
摘要
糖尿病足是糖尿病较为严重的并发症之一,已知的糖尿病足溃疡的危险因素包括高龄、长期糖尿病史、高血糖、视觉病变、外周血管病变、慢性。肾病等全身性或系统性因素和溃疡或截肢病史、周围神经病变、
出处
《浙江医学》
CAS
2012年第11期957-958,共2页
Zhejiang Medical Journal
参考文献7
-
1陈炯,胡行.糖尿病足:临床操作指南[M].天津:天津科学技术出版社,2009:13.
-
2麦超,简华刚.晚期糖基化终末产物与糖尿病足[J].检验医学与临床,2010,7(10):999-1001. 被引量:6
-
3Holman R R, Paul S K, Bethel M A, et al.1 O-year follow-up of intensive glucose control in type 2 diabetes[J]. N Engl J Med, 2008,359:1577-1589.
-
4Noordzij M J,Lefrandt J D,Graaff R,et aI.Skin autofluorescence and glycemic variability[J]. Diabetes Technol Ther,2010,12:581 - 585.
-
5Facchiano F,Lentini A,Fogliano V,et al. Sugar-induced modifi- cation of fibroblast growth factor 2 reduces its angiogenic activity in vivo[J].Am J Pathol,2008,161:531-541.
-
6Portero-Otin M,Pamplona R,Bellmunt M J,et aI.Advanced glyca- tion end product precursors impair epidermal growth factor re- ceptor signaling[J]. Diabetes,2007,51 : 1535-1542.
-
7Peppa M,Brem H,Ehdich P,et al .Adverse effects of dietary gly- cotoxins on wound healing in genetically diabeticmice [J].Dia- betes, 2007,52: 2805- 2813.
二级参考文献25
-
1Lorenzi M.Glucose toxicity in the vascular complications of diabetes:the cellular perspective[J].Diabetes Metab Rev,1999,8(2):85-103.
-
2Pamplona R,Bellmunt MJ,Portero M,et al.Mechanisms of glycation in atherogenesis[J].Med Hypotheses,2005,40(3):174-181.
-
3Shinohara M,Thornalley PJ,Giardino I,et al.Overexpression of glyoxalase-Ⅰ in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis[J].J Clin Invest,2008,101:1142-1147.
-
4Sugaya K,Fukagawa T,Matsumoto K,et al.Three genes in the human MHC class Ⅲ region near the junction with the class Ⅱ gene for receptor of advanced glycosylation end products,PBX2 homeobox gene and a notch homolog,human counterpart of mouse mammary tumor gene int-3[J].Genomics,2004,23:408-419.
-
5Yan SF,Ramasamy R,Naka Y,et al.Glycation,inflammation,and RAGE:a scaffold for the macrovascular complications of diabetes and beyond[J].Circ Res,2007,93:1159-1169.
-
6Kislinger T,Fu C,Huber B,et al.N -(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression[J].J Biol Chem,1999,274:31740-31749.
-
7Schmidt AM,Yan SD,Yan SF,et al.The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses[J].J Clin Invest,2007,108:949-955.
-
8Makino H,Shikata K,Kushiro M,et al.Roles of advanced glycation end-products in the progression of diabetic nephropathy[J].Nephrol Dial Transplant,2006,11(Suppl 5):76-80.
-
9Striker LJ,Striker GE.Administration of AGEs in vivo induces extracellular matrix gene expression[J].Nephrol Dial Transplant,2006,11(Suppl 5):62-65.
-
10Throckmorton DC,Brogden AP,Min B,et al.PDGF and TGF-? mediate collagen production by mesangial cells exposed to advanced glycosylation end products[J].Kidney Int,2005,48:111-117.
共引文献5
-
1修丽梅,温金莉,曹建春,王吉亭,曹刚,李光宗,黄强,尚宪荣,刘继前,王亚娜,施萍,罗毅文.“赵氏脱疽方”干预AGEs及糖尿病足相关因子的研究[J].中国中医基础医学杂志,2012,18(1):69-70. 被引量:2
-
2修丽梅,王振平,严雪梅,张丽娜,魏军平,施萍,王亚娜.糖尿病足微血管病变及其药物治疗的研究进展[J].世界中西医结合杂志,2012,7(6):532-534. 被引量:16
-
3徐杰男,阙华发,唐汉钧,黄高敏,诸炳骅,李星子.益气化瘀方促进糖尿病难愈创面血管新生的AGEs/RAGE/NF-κB信号通路研究[J].辽宁中医杂志,2016,43(1):154-158. 被引量:16
-
4邢美艳,姜天,夏莉,张一,许娟,罗莉,胡红琳,赵广碧,刘勇,王贻坤,夏营威,章秋.皮肤无创晚期糖基化终末产物测定在社区2型糖尿病血管性并发症筛查中的作用研究[J].中国全科医学,2020,23(8):913-915. 被引量:9
-
5徐杰男,阙华发,李星子,诸炳骅.益气化瘀方促进糖尿病难愈创面修复愈合的AGEs/RAGE/KCs调控机制研究[J].时珍国医国药,2020,31(9):2074-2078. 被引量:3
同被引文献11
-
1全国老龄工作委员会办公室.中国人口老龄化发展趋势预测研究报告[EB/OL].[2006-02-24].http://www.xinhuanet.com/newscenter/.
-
2国际糖尿病足工作组.糖尿病足国际临床指南[M].北京:人民军医出版社,2004:6-9.
-
3Fu X,Sheng Z,Cherry GW,et al. Epidemiological study of chronic der- mal ulcers in China[J]. Wound Repair Regen,1998,6(1):21 -27.
-
4Jiang Y,Huang S,Fu X,et al. Epidemiology of chronic cutaneous wound in China[J]. Wound Repair Regen,2011,19(2) :181 -188.
-
5Yang W,Lu J,Weng J,et al. China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China[J]. N Engl J Med,2010,362(12) :1090 -1101.
-
6National Pressure Ulcer Advisory Panel (NPUAP). Support Surface Ini- tiative. NPUAP, Support surface standards initiative-terms and defini- tions. Available: https ://www. upuap, org. accessed June,2006.
-
7O' Donnell TF Jr, Passman MA, Marston WA, et al. Management of venous leg ulcers: clinical practice guidelines of the Society for Vas- cular Surgery and the American Venous Forum [J].J Vase Surg, 2014,60(2S) :3S -59S.
-
8Goh SY, Cooper ME. The role of advanced glycation end products in progression and complicatians of diabetes [ J ]. J Clin Endocrinol Metab,2008,93 (4) : 1143 - 1152.
-
9Noordzij MJ,Lefrandt JD,Graaff R,et al. Skin autafluorescence and gly- cemic variability[J]. Diabetes Technol Ther,2010,12(7) :581 - 585.
-
10Liu C, Xu L, Gao H, et al. The association between skin autofluores- cence and vascular complications in Chinese patients with diabetic foot ulcer: an observational study done in Shanghai [ J ]. Int J Low Extrem Wounds , 2015 ,14 ( 1 ) :28 - 36.
二级引证文献7
-
1董炜,肖玉瑞,吴敏洁,姜笃银,聂兰军,刘英开,唐佳俊,田鸣,王春兰,黄丽芳,董叫云,曹晓赞,宋菲,嵇晓芸,马先,康雨田,金曙雯,青春,陆树良.中国慢性难愈性创面诊疗思路及原则[J].中华烧伤杂志,2018,34(12):868-873. 被引量:69
-
2郭皞.难愈性创面39例临床治疗结果分析[J].中国药物与临床,2017,17(12):1828-1830. 被引量:4
-
3王永灵,廖明娟,李琰,蒉纲.中医外治疗法结合阳和汤加减治疗糖尿病足创面的疗效分析[J].足踝外科电子杂志,2019,6(3):25-26. 被引量:4
-
4段云蔚,闵定宏,廖新成,郭光华.负压伤口治疗技术在修复慢性难愈性创面中的应用[J].南昌大学学报(医学版),2019,59(6):43-46. 被引量:15
-
5王永灵,廖明娟,李琰,蒉纲.阳和汤加减结合负压技术治疗糖尿病足65例[J].中医外治杂志,2020,29(2):50-51. 被引量:2
-
6顾佳,邰宁正.慢性窦道创面的治疗进展[J].安徽医学,2021,42(6):699-702. 被引量:4
-
7谢挺,倪鹏文,韩春茂,温冰,肖健,王泠,姜玉峰,蒋琪霞,罗蔓.中国创面修复学科发展的新阶段:规范及融合与转化[J].中华烧伤与创面修复杂志,2023,39(11):1001-1005. 被引量:1
-
1牛锋.替罗非班在不同入径经皮冠状动脉介入术治疗急性冠状动脉综合征中的出血风险评价[J].中国心血管杂志,2016,21(6):470-474. 被引量:2
-
2宋芝萍,陈耀光,张大东.甲状腺功能亢进合并心房颤动患者缺血性脑卒中的风险评价[J].临床心血管病杂志,2010,26(6):471-472. 被引量:3
-
3王妍,李宇,韩智红,姜腾勇.老年人肥厚型心肌病[J].中华老年医学杂志,2009,28(11):921-923.
-
4鞠晓红,方德洋,马爱新,方芳.C-反应蛋白水平的性别和年龄差异[J].广东医学,2007,28(6):923-924. 被引量:4
-
5王琳,侯明.原发免疫性血小板减少症出血评分系统[J].中华血液学杂志,2015,36(12):1053-1055. 被引量:16
-
6华扬.超声检查在缺血性脑血管病诊治中的应用[J].中华脑血管病论坛,2005,3(5):461-462.
-
7李焱.降糖药物低血糖风险评价[J].药品评价,2012(1):25-26. 被引量:2
-
8何倩雯,冯英,文印宪,周游,王扬淦.ACEI/ARBCEI/ARB治疗舒张性心力衰竭疗效及安全性的系统评价[J].中国循证医学杂志,2015,15(6):672-680. 被引量:10
-
9刘良田,李屏,吴小花.联合检测NT-proBNP、H-FABP和cTnI对老年重症心力衰竭患者的临床价值[J].中国医学创新,2016,13(10):15-19. 被引量:12
-
10戴廉.以欧洲为榜样 访欧盟委员会健康与消费者总司公共健康与风险评价司司长Andrzej Rys[J].中国医院院长,2010,6(21):62-64.